FreeTCCL Archive Volasertib and LDAC Doubled Response in Older Acute Myeloid Leukemia Patients July 31, 2014Vol.37 No.07
FreeTCCL Archive Somatuline Demonstrates 65.1 Percent of Gastroenteropancreatic Neuroendocrine Tumor Patients Progression-Free at 96 Weeks July 31, 2014Vol.37 No.07
FreeTCCL Archive IDMC Halts Mekinist-Tafinlar Melanoma Trial Early Due to OS Benefit; Recommends Crossover July 31, 2014Vol.37 No.07
FreeTCCL Archive Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Colorectal Cancer Trial July 31, 2014Vol.37 No.07
FreeTCCL Archive Vaccine Increases PFS by 4 Months in Phase II Per-Protocol Analysis June 30, 2014Vol.37 No.06
FreeTCCL Archive Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months June 30, 2014Vol.37 No.06
FreeTCCL Archive Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III June 30, 2014Vol.37 No.06
